This study aims to investigate the effects of a 12-week multimodal exercise intervention on middle-aged and older adults (aged 45\~85 years) with Type 2 Diabetes Mellitus (T2DM). The program combines supervised training, home-based sessions, and digital support to improve muscle function, physical performance, metabolic control, and quality of life.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Physical Function (5TSTS)
Timeframe: Change from Baseline at Week 12 and Week 24
Handgrip Strength (HGS)
Timeframe: Change from Baseline at Week 12 and Week 24
Skeletal Muscle Mass Index (SMI)
Timeframe: Change from Baseline at Week 12 and Week 24
Sarcopenia Risk: Assessed using the Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls (SARC-F) questionnaire combined with calf circumference measurement (SARC-CalF).
Timeframe: Change from Baseline at Week 12 and Week 24